EUVIMEDEUVIMED entdecken
Leitlinie

Guidelines for surveillance of patients with von Hippel‐Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance

Anthony B Daniels, Amit Tirosh iD, Kristin Huntoon, Gautam U Mehta, Philippe E Spiess, Debra L Friedman, Steven G Waguespack, Jill E Kilkelly, Surya Rednam, Sumit Pruthi, Eric A Jonasch, Laura Baum iD und 2 weitere

Cancer · 2023-10 · 129 (19) · 2927-2940

DOI: 10.1002/cncr.34896 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Cancer, online erschienen am 19.06.2023. Verfasst von Anthony B Daniels und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Ocular Oncology and Pathology, Department of Ophthalmology & Visual Sciences, Vanderbilt University Medical Center, Nashville, Tennessee,…. Hauptthemen laut MEDLINE: von Hippel-Lindau Disease. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 89 Literaturangaben. Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Von Hippel‐Lindau disease is a rare inherited cancer‐predisposition syndrome. The authors report the updated recommendations for the multiorgan surveillance protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Hippel-Lindau DiseaseHumansVon Hippel-Lindau Tumor Suppressor ProteinPatients

Stichwörter der Autor:innen

VHLendolymphatic sac tumorshemangioblastomaskidney cancerpancreatic neuroendocrine tumorspheochromocytomarenal cell cancervon Hipple-Lindau syndrome

Substanzen

Von Hippel-Lindau Tumor Suppressor ProteinVHL protein, human

Autor:innen und Institutionen

  • Division of Ocular Oncology and Pathology, Department of Ophthalmology & Visual Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Neuroendocrine Tumors Service, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Tennessee, USA.
  • The House Clinic, Los Angeles, California, USA.
  • Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida, USA.

ORCID-Profile: Amit Tirosh, Laura Baum, Jad Chahoud

Förderung

  • NEI NIH HHS

Zitieren

APA

Daniels, A. B., Tirosh, A., Huntoon, K., Mehta, G. U., Spiess, P. E., Friedman, D. L., Waguespack, S. G., Kilkelly, J. E., Rednam, S., Pruthi, S., Jonasch, E. A., Baum, L., Chahoud, J., & International VHL Surveillance Guidelines Consortium (2023). Guidelines for surveillance of patients with von Hippel‐Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance. Cancer, 129(19), 2927-2940. https://doi.org/10.1002/cncr.34896

Vancouver

Daniels AB, Tirosh A, Huntoon K, Mehta GU, Spiess PE, Friedman DL, et al. Guidelines for surveillance of patients with von Hippel‐Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance. Cancer. 2023;129(19):2927-2940. doi:10.1002/cncr.34896

BibTeX
@article{Daniels2023,
  author = {Daniels, Anthony B and Tirosh, Amit and Huntoon, Kristin and Mehta, Gautam U and Spiess, Philippe E and Friedman, Debra L and Waguespack, Steven G and Kilkelly, Jill E and Rednam, Surya and Pruthi, Sumit and Jonasch, Eric A and Baum, Laura and Chahoud, Jad and International VHL Surveillance Guidelines Consortium, International VHL Surveillance Guidelines Consortium},
  title = {Guidelines for surveillance of patients with von Hippel‐Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance},
  journal = {Cancer},
  year = {2023},
  volume = {129},
  number = {19},
  pages = {2927--2940},
  doi = {10.1002/cncr.34896}
}
Kostenlos starten →